Ionis Pharmaceuticals, Inc. (IONS)
NGS · Common · CUSIP 462222100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IONS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
462222100 (prev. 464330109 )
Market Cap
Large Cap
Previous Symbol
ISIS (changed 12/21/2015)
Previous Name
Isis Pharmaceuticals, Inc.
Business: Ionis Pharmaceuticals, Inc. is a sustainably profitable, multi-product company with a pipeline of more than 40 first-in-class and/or best-in-class medicines. Using its proprietary antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development.

Company Contact

CEO
Brett P. Monia
CFO
Elizabeth L. Hougen
Headquarters
2855 Gazelle Court, Carlsbad, CA 92010
Phone
760-931-9200
Investor Relations
D. Wade Walke, Ph.D. · 760-603-2331
Email Form
Contact Form »
SEC EDGAR Filings
View filings »